The global newborn screening market size was US$ 1.1 billion in 2021. The global newborn screening market size is forecast to reach US$ 2.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period from 2022 to 2030.

Newborn screening detects conditions that may have a long-term impact on a child's health or survival. This screening method consists of a battery of tests that are necessary for early identification, diagnosis, and health care in order to prevent overall handicap and a child's death. These tests reveal genetic, developmental, and metabolic problems in newborn babies and are conducted shortly after the baby is delivered. Prior to discharge from a hospital or birthing facility, a few drops of blood from the newborn's heel are tested for specific genetic, endocrine, metabolic diseases, hearing loss, and catastrophic congenital heart abnormalities (CCHDs).

Factors Influencing Market Growth
Increasing government support for newborn screening and expansion in screening technology fuel the global market growth.
Among the factors driving the global market include the increasing birth rate and the growing incidence of neonatal diseases.
Lack of advancement in healthcare infrastructure and the restricted number of trained professionals may slow down the overall market growth.
Rising genetic disorders screening due to the rise in birth rates and growing disposable income offers lucrative opportunities for the global market during the forecast period.

Impact Analysis of COVID-19
COVID-19 pandemic negatively affected the global newborn screening market. Due to mail delays, unreliability, and airline cancellation, samples arriving at screening locations and the availability of laboratory equipment and reagents had delayed. Laboratory personnel availability had to occasionally reduce due to infection, quarantine, or relocation within the healthcare center. Samples at home collection, second-tier tests, and follow-up were all affected. Social restrictions and public transportation delays exacerbated these problems. Only a few centers were maintaining full operation of their NBS (newborn screening) programs.

Regional Insights
North America garnered the major market share in 2021 and is forecast to maintain its position during the forecast period. As a result of the easy availability of newborn screening programs, profitable reimbursement policies, and substantial market participant presence.

The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the growing population rates, rising birth rates, and an increase in congenital disease cases.

Leading Competitors
The leading prominent companies profiled in the global newborn screening market are:
Ab Sciex LLC
Agilent Technologies Incorporated
Bio-Rad Laboratories Incorporated
Covidien Plc
Ge Healthcare
PerkinElmer Incorporated
Masimo Corporation
Natus Medical Incorporated
Trivitron Healthcare
Waters Corporation
Other Prominent Players

Scope of the Report
The global newborn screening market segmentation focuses on Product Type, Test Type, Technology, End-User, and Region.
Segmentation based on Product Type
Instrument
Consumables
Segmentation based on Test Type
Blood test
Hearing screening test
Heart screening
Segmentation based on Technology
Tandem Mass Spectrometry (TMS)
Molecular Assays
Immunoassays and Enzymatic Assays
Hearing Screen Technology
Pulse Oximetry Screening Technology
Others
Segmentation based on End-User
Hospitals
Clinical laboratories
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Newborn Screening Market Size, Share, Insight and Forecast 2022 To 2030
Meta Description: Global Newborn Screening Market is projected to reach US$ 2.0 billion by end of 2030 from US$ 1.1 billion in 2021, at a CAGR of 6.8%
Meta Keywords: newborn screening market Size, newborn screening market share, newborn screening market trend, newborn screening market Forecast, newborn screening market insight